4D Molecular Therapeutics, Inc 10-K for FY2020
4D Molecular Therapeutics, Inc. (FDMT)
10-K
2021-03-25
For: 2020-12-31
View Original
Added on
April 08, 2026
About this 10-K
4D Molecular Therapeutics, Inc filed this 10-K on March 25, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13.61M
- up 94.8% from $6.99M a year earlier
- Net loss
- $56.69M
- compared with a net loss of $49.31M a year earlier